SMTL ID : 4rvi.1 (1 other biounit)

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with non-peptidic inhibitor, GRL0519

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

homo-dimer

Ligands

1 x G52: (3R,3aS,3bR,6aS,7aS)-octahydrodifuro[2,3-b:3',2'-d]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}propyl]carbamate(Non-covalent)

G52.1: 25 residues within 4Å: Chain A: R.8, L.23, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, P.81, T.82, I.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, T.82 19 PLIP interactions: 11 interactions with chain A, 8 interactions with chain B Hydrophobic interactions: A:L.23, A:A.28, A:V.32, A:I.47, A:P.81, A:T.82, A:I.84, B:L.23 Hydrogen bonds: A:D.30, A:I.50, B:D.25, B:G.27, B:G.27, B:D.29, B:D.30 Salt bridges: A:R.8, A:D.25, B:D.25 Water bridges: B:I.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yedidi, R.S. et al., Enhanced antiviral activity by the P2-tris-tetrahydrofuran moiety of GRL-0519, a novel nonpeptidic HIV-1 protease inhibitor (PI), against multi-PI-resistant and highly darunavir-resistant strains of HIV-1. To be Published

Release Date

2016-05-04

Peptides

HIV-1 protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV-1 protease

Related Entries With Identical Sequence